HTL Announces Its Incubator’s Equity Investment In GelMEDIX, An Early-Stage Biotech Aiming At Revolutionizing Ocular And Regenerative Therapies

TOPICS:

Posted By: Advance March 10, 2022

/PRNewswire/ — HTL Biotechnology, a pioneer and world leader in the development and production of innovative pharmaceutical grade biopolymers, today announced…